Bio Protocol Breaks Records Amidst Whale Buying Mania
Bio Protocol (BIO) reached new heights this week,skyrocketing to $0.2390. The token gained over 450% as its lowest point this year.
The surge coincides with increased investor optimism around Aubrai, the platform’s first decentralized scientific agent, launching on August 25. This innovation, created with VitaDAO, targets human longevity and anti-aging research.
The ignition sale attaches a fully diluted value of $269,000. Post-sale, AUBRAI token valuation approaches $900,000.
Nansen data reveals extensive whale participation. Whales now hold 21.94 million BIO tokens—a 980% hike in 30 days. Exchange outflows fell from 483 million to 439 million, reflecting ongoing buying interest.
- DeSci initiatives thrive on fundraising via decentralized autonomous organizations (DAOs).
- Cerebrum DAO granted $80,000 to Percepta for memory loss research.
- HairDAO boasts a $66.5 million valuation; VitaDAO holds $59 million.
Technical analysis indicates the BIO price may face a pullback. The Relative Strength Index stands at 82—suggesting overbuying. Traders anticipate potential corrections near $0.1435 and $0.1012.
Despite risks, the Bio Protocol rally signals strong faith in DeSci’s future and underlines the platform’s disruptive potential in global research funding.
